A translational mechanistic synthesis of ischemia–reperfusion injury in experimental flap models toward free flap salvage
-
By
-
April 20, 2026
Objective:
To identify reproducible mechanistic signatures linked to improved viability in ischemia-reperfusion injury and to build a practical translational framework for high-risk ischemia scenarios and free flap salvage.
Key Findings:
- Effective interventions demonstrated a reproducible biological signature: attenuation of lipid peroxidation, suppression of neutrophil-mediated inflammation, restoration of antioxidant defenses, and preservation of nitric oxide bioavailability, which are critical for clinical application.
- Trimetazidine, propionyl-L-carnitine, and lutein improved survival area in severe ischemia models compared to controls, indicating potential therapeutic options.
- Surgical conditioning strategies like venous flap pre-arterialization and delay procedures achieved near-complete viability in experimental models, suggesting their relevance in clinical settings.
Interpretation:
Flap I/R injury follows a consistent oxidative stress–inflammation–microvascular dysfunction axis, with interventions targeting multiple components showing protective effects across severe ischemia conditions, highlighting the need for integrated treatment approaches.
Limitations:
- Findings from experimental models may not directly translate to acute free flap salvage scenarios due to differences in biological responses.
- Heterogeneity in flap type, ischemia duration, and outcome definitions limits direct comparisons and applicability of results to clinical practice.
Conclusion:
The study establishes a translational mechanistic framework to guide adjunctive strategies in high-risk free flap protocols, supporting prospective clinical integration in microsurgical salvage scenarios.
